chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: F
Vaccine: HEPA
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Gave an Adult dose HAVRIX to an 18 year old patient at an off site clinic. No adverse events reported.
Age: 33.0
Sex: M
Vaccine: ANTH
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: 6th course of Anthrax vaccine. No previous reactions. Injection site appears similar to insect sting.  Swelling, redness, tenderness, painful, hot to the touch, itchy, right upper arm. Symptoms appeared morning after injection and have not subsided. Injection was more painful than normal.  Will visit clinic tomorrow. Pamphlet provided listed these symptoms as normal; I disagree.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Body temperature, Chills, Headache, Somnolence
Clinical narrative: Headache, shivers, temperature, sleepiness. Took TYLENOL every 8 hours. Felt better by 06/23/2018.
Age: 80.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Pruritus
Clinical narrative: PATIENT STATES THAT THE DAY OF THE VACCINATION HER ARM WAS ITCHY AT THE SITE OF INJECTION, THEN IT STOPPED THE NEXT DAY, BUT THEN TWO DAYS AFTER THE VACCINATION IT RETURNED AND THE WHOLE ARM WAS ITCHY. THERE WAS NO SWELLING THOUGH.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site cellulitis, Injection site erythema, Injection site induration, Injection site irritation, Injection site pain
Clinical narrative: Patient reported, upon injection, she experienced severe pain. Noted it was more painful than standard flu vaccine. Patient stated from the point of injection until today (6/24/2018) injection site was hot to touch, and was very hard underneath and surrounding. Patient showed me injection site, it was red in color, with scarring that resembled aftermath of a tetanus vaccine or ringworm within a 10-12 cm circle which was hardened underneath skin. Patient reported pain 10 on pain scale of 1-10. She reported this to me and my findings were observed when she returned to the pharmacy to pick up medication for treatment of cellulitis due to the vaccination.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site scar, Injection site warmth
Clinical narrative: Patient reported, upon injection, she experienced severe pain. Noted it was more painful than standard flu vaccine. Patient stated from the point of injection until today (6/24/2018) injection site was hot to touch, and was very hard underneath and surrounding. Patient showed me injection site, it was red in color, with scarring that resembled aftermath of a tetanus vaccine or ringworm within a 10-12 cm circle which was hardened underneath skin. Patient reported pain 10 on pain scale of 1-10. She reported this to me and my findings were observed when she returned to the pharmacy to pick up medication for treatment of cellulitis due to the vaccination.
Age: 64.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Chills, Headache, Myalgia, Pyrexia, Tremor
Clinical narrative: Sudden onset of uncontrolled shivering/shaking, fever 100.5, headache, myalgias, lasted approx. most severe symptoms lasted about six hours and then gradually subsided over additional 6 hours.
Age: 64.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Feeling cold, Injection site pain, Insomnia, Pyrexia, Tremor
Clinical narrative: Sudden onset of uncontrolled shivering/shaking, fever 100.5, headache, myalgias, lasted approx. most severe symptoms lasted about six hours and then gradually subsided over additional 6 hours.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Axillary pain, Decreased appetite, Dizziness, Myalgia
Clinical narrative: Severe sharp pain under left arm/ in armpit. Multiple muscle aches dizziness weakness slept whole day yesterday loss of appetite.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Somnolence
Clinical narrative: Severe sharp pain under left arm/ in armpit. Multiple muscle aches dizziness weakness slept whole day yesterday loss of appetite.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chills, Headache, Myalgia, Nausea
Clinical narrative: Headache, myalgias. chills, mild nausea.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chills, Feeling cold, Injection site pain, Musculoskeletal pain, Myalgia
Clinical narrative: Headache, myalgias. chills, mild nausea.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Nausea, Pyrexia
Clinical narrative: Headache, myalgias. chills, mild nausea.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Chills, Headache, Hypersensitivity, Injection site pain, Malaise
Clinical narrative: Headache, myalgias. chills, mild nausea.
Age: 68.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Myalgia, Nausea, Pyrexia, Tremor
Clinical narrative: Headache, myalgias. chills, mild nausea.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Neck pain, Pain
Clinical narrative: Patient experienced pain radiating from elbow to upper neckline.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Bursitis, Injected limb mobility decreased, Pain, Peripheral swelling, Shoulder injury related to vaccine administration
Clinical narrative: Patient came into pharmacy 6/24/18 asking about her reaction to the SHINGRIX. What she seemed to describe was a SIRVA and bursitis due to poor injection technique. She complained about swelling, limited arm/shoulder movement and pain. She went to the doctors to have it check out and the doctor told the patient to come to the pharmacy and ask about possible reactions to the vaccine. The patient's arm movement has returned to almost normal and most of the pain has subsided though it is still a bit tender.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Tenderness, Wrong technique in product usage process
Clinical narrative: Patient came into pharmacy 6/24/18 asking about her reaction to the SHINGRIX. What she seemed to describe was a SIRVA and bursitis due to poor injection technique. She complained about swelling, limited arm/shoulder movement and pain. She went to the doctors to have it check out and the doctor told the patient to come to the pharmacy and ask about possible reactions to the vaccine. The patient's arm movement has returned to almost normal and most of the pain has subsided though it is still a bit tender.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Cold sweat, Dizziness
Clinical narrative: Patient felt faint/lightheaded had a cold sweat and had to be laid on her back. Blood pressure was normal HR was normal. EMS was called but patient was able to get up on her own power and was escorted back home after refusing transportation to the hospital.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site pain, Musculoskeletal stiffness, Myalgia, Neck pain
Clinical narrative: Soreness, stiffness at injection area radiating to upper shoulder, neck and collarbone area. Extreme fatigue, symptoms similar to fighting minor infection or virus, i.e. muscle aches.
Age: 54.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Right Arm injection site reaction after SHINGRIX given on 6/22/18 presented to the Pharmacy on 6/24/18. Raised red spot about 2 inches long and 1.5 inches wide with pain surrounding the entire area up to the top of her shoulder.
Age: 77.0
Sex: F
Vaccine: PNC13, TDAP, VARZOS
Symptoms: Erythema, Pain in extremity, Pruritus, Skin warm
Clinical narrative: Her arm was red and a little sore after given the vaccines. Each day afterwards redness has spread upwards and after 2 days became itchy and hot. The redness was just below the shoulder and she wanted to report this. I told her to use some ice and also some BENADRYL cream. If it continued to spread to go seek medical attention. I also gave her another copy of the VIS sheets for each vaccination because she did not know where hers went.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Received injection 6/22/18 and noticed symptoms 6/24/18. At the injections site skin was red and tender. Patient was advised to ice the site at the time of injection and had not done so but would do it now. Advised patient to watch for worsening of symptoms of if unresolved to seek medical attention. Patient stated that she has an appointment with her PCP this coming week and will inform her of the reaction and have her evaluate the injection site.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Myalgia, Nausea, Vomiting
Clinical narrative: Dose #1...... very mild reaction nausea. Dose #2......more noticeable reaction with nausea/vomiting, shivering/chills, muscle aches.
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: I saw the left deltoid on 04/19/2018. The area was swollen and red. 4 inches wide and 4 1/2 inches long was the area of redness and swelling. The left deltoid arm area circumference was 9 1/4 inches. The right deltoid area circumference was 7 3/4 inches.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Oral herpes
Clinical narrative: Patient experienced fever blisters around the mouth and area up to the nose a couple of days after receiving shot. She also noticed a blister appear on an area on the hip where she previously had shingles. She experienced the fever blisters after the first and second dose of SHINGRIX.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Asthenia, Chills, Confusional state, Fatigue, Nausea
Clinical narrative: EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Pain, Syncope
Clinical narrative: EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Balance disorder, Confusional state, Cough, Fatigue, Feeling abnormal
Clinical narrative: EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Middle insomnia, Nasopharyngitis, Nausea, Pain in extremity, Somnolence
Clinical narrative: EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Syncope
Clinical narrative: EXTREME FATIGUE, CHILLS, WEAKNESS, NAUSEA, BODY ACHES, CONFUSION, FAINT.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Asthenia, Chills, Fatigue, Headache
Clinical narrative: Red, swollen and sore upper left arm for 5 days. Shivering and Fever for approximately 30 hours, followed by 2 days of upset stomach and 4 days of Headache, Fatigue, Weakness, and general Achiness.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pain, Pyrexia
Clinical narrative: Red, swollen and sore upper left arm for 5 days. Shivering and Fever for approximately 30 hours, followed by 2 days of upset stomach and 4 days of Headache, Fatigue, Weakness, and general Achiness.
Age: 69.0
Sex: M
Vaccine: PNC13
Symptoms: Fatigue, Injection site erythema, Nausea, Pain, Peripheral swelling
Clinical narrative: On the first day: mild fever, body aches, extreme fatigue, mild nausea, redness at the injection site. On the second day: all of the symptoms of the first day. In addition, a raspberry colored blotch extending downward from the shoulder down to approximately half of the bicep and hot to the touch. On the third day: normal temperature, the red bloch extended downward and under  the arm reaching close to the elbow with swelling of the affected area. On the fourth day the swelling increased.
Age: 69.0
Sex: M
Vaccine: PNC13
Symptoms: Pyrexia, Rash, Rash macular, Skin warm
Clinical narrative: On the first day: mild fever, body aches, extreme fatigue, mild nausea, redness at the injection site. On the second day: all of the symptoms of the first day. In addition, a raspberry colored blotch extending downward from the shoulder down to approximately half of the bicep and hot to the touch. On the third day: normal temperature, the red bloch extended downward and under  the arm reaching close to the elbow with swelling of the affected area. On the fourth day the swelling increased.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Headache, Injected limb mobility decreased, Injection site joint pain, Joint stiffness, Limb discomfort
Clinical narrative: I had a very bad reaction after the vaccine PPSV23 was given to me on June 4 at around 11:00 am. A couple hrs afterwards I noticed there was a slight headache and I felt the left upper arm where the injection was given was getting heavier and heavier. This did not both me too much thinking it was a normal reaction after vaccines. The injection was given at the muscle at the top of my left arm close to my left shoulder. At around 4 pm, 5 hours after the vaccine, I had the most excruciating pain at my left shoulder joint caused by the vaccine injection for at least 12 hours. The pain was 10 in a scale of 1 to 10. Tylenol and NSAIDs and ice offered to help. I wanted to die. The pain went to my neck, not only did I not able to lift my left arm, I could not even move my left hand. The throbbing pain travelled to the palm of my hand. I had fever. I felt better the next day and there was still pain but the pain was bearable even though I still could not move my left arm. It took a week for the pain to be gone and for me to be able to lift my left arm. Even today, 20 days after the vaccine, my left shoulder joint still feel stiff. I never have problem with my shoulders before. The adverse reaction was reported to the doctor thru email the next day and she told me to report to CDC myself. She advised to apply ice on the area for a few days.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Neck pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: I had a very bad reaction after the vaccine PPSV23 was given to me on June 4 at around 11:00 am. A couple hrs afterwards I noticed there was a slight headache and I felt the left upper arm where the injection was given was getting heavier and heavier. This did not both me too much thinking it was a normal reaction after vaccines. The injection was given at the muscle at the top of my left arm close to my left shoulder. At around 4 pm, 5 hours after the vaccine, I had the most excruciating pain at my left shoulder joint caused by the vaccine injection for at least 12 hours. The pain was 10 in a scale of 1 to 10. Tylenol and NSAIDs and ice offered to help. I wanted to die. The pain went to my neck, not only did I not able to lift my left arm, I could not even move my left hand. The throbbing pain travelled to the palm of my hand. I had fever. I felt better the next day and there was still pain but the pain was bearable even though I still could not move my left arm. It took a week for the pain to be gone and for me to be able to lift my left arm. Even today, 20 days after the vaccine, my left shoulder joint still feel stiff. I never have problem with my shoulders before. The adverse reaction was reported to the doctor thru email the next day and she told me to report to CDC myself. She advised to apply ice on the area for a few days.
Age: 1.08
Sex: F
Vaccine: HEPA, HIBV, VARCEL
Symptoms: Irritability, Pain, Pyrexia, Swelling, Tenderness
Clinical narrative: Local swelling, tenderness, and pain; fever, irritability. Began 10D after vaccines. Local swelling improved as of 2D later, but continued irritability. No vesicles.
Age: 57.0
Sex: U
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Arthralgia, Chills, Headache, Myalgia
Clinical narrative: 2 Hrs after: upset stomach, shivering. 12 Hrs after: headache, muscle pain, joint pain. 24 Hrs after: fever, hives above and below injection site. 3 days after: Ringing in ears.
Age: 57.0
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia, Tinnitus, Urticaria
Clinical narrative: 2 Hrs after: upset stomach, shivering. 12 Hrs after: headache, muscle pain, joint pain. 24 Hrs after: fever, hives above and below injection site. 3 days after: Ringing in ears.
Age: 29.0
Sex: M
Vaccine: HEPAB, TYP
Symptoms: Loss of consciousness
Clinical narrative: Patient appeared to lose consciousness moments after administration of 2nd vaccine (TWINRIX). RPh and pt's companion supported him and RPh confirmed pulse/breathing. PRh dialed 911, and patient regained consciousness as 911 operator picked up. Pt and companion refused RPh offer to call EMS to the pharmacy location. Pt was provided orange juice and he rested before leaving in friend's car. One day later, pt's friend confirmed he was feeling better and had appt.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 31-JUL-2015, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 30-JUN-2016, the patient was treated at a hospital for the onset of a severe vesicular rash, which was diagnosed as shingles. The patient was prescribed KEFLEX and acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Back pain, Musculoskeletal pain, Pain, Pain in extremity, Product administered at inappropriate site
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 704259) concerns a 65-year-old, elderly female patient. The patient's medical history included high cholesterol and had no allergies. The concomitant medications included SYNTHROID, vitamin D, calcium and Baby aspirin. On 11-Nov-2016, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported) too high in the arm (explicitly coded as vaccine administration at inappropriate site). On the same day, (reported as within 5 minutes), the patient developed intense pain in shoulder which radiated to back and down the arm at times. The patient reported that, sleeping on right side was painful and interfered the sleep. It was reported that, full movement of the shoulder was possible, but pain during movements varied from strong to mild. Intense pain lasted approximately for 3 days. The patient began exercises to strengthen muscles to fix shoulder. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Sleep disorder
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 704259) concerns a 65-year-old, elderly female patient. The patient's medical history included high cholesterol and had no allergies. The concomitant medications included SYNTHROID, vitamin D, calcium and Baby aspirin. On 11-Nov-2016, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number, expiry date: not reported) too high in the arm (explicitly coded as vaccine administration at inappropriate site). On the same day, (reported as within 5 minutes), the patient developed intense pain in shoulder which radiated to back and down the arm at times. The patient reported that, sleeping on right side was painful and interfered the sleep. It was reported that, full movement of the shoulder was possible, but pain during movements varied from strong to mild. Intense pain lasted approximately for 3 days. The patient began exercises to strengthen muscles to fix shoulder. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Acupuncture, Mobility decreased
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 705608), concerns a 65-year-old, elderly, female patient. On 16-Sep-2016, the patient was administered with FLUAD (TIV) (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: 165801 and expiry date: not reported). On 17-Sep-2016, after 1 day of vaccination, the patient was unable to move her arm for 3 days. The patient reported that, she was unable to join the hands behind her back and it was still hard to raise her arm over the head. On an unspecified date, the patient consulted doctor of medicine (MD) and acupuncture was done on unspecified date in Mar, which helped (as reported). At the time of this report, the outcome of the event was not recovered. The reporter considered the case as non-serious.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Blood pressure increased, Dyspnoea, Heart rate increased, International normalised ratio increased, Malaise
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 707300) concerns a 71-year-old female patient. The patient's historical condition included atrial fibrillation (A-fib as reported). The patient's historical drug included ELIQUIS. The patient's concomitant medications included Triamterene and hydrochlorothiazide, metformin, JANTOVEN, clonazepam, pantoprazole, promethazine. It was reported that, the patient underwent several heart related procedures. On 04-Aug-2017, the patient was administered with FLUAD (dose: 0.5ml (N/A as reported), route of administration: injection, anatomical location: left arm, batch number: 178301). On 05-Aug-2017, 1 day after vaccination, the patient felt sick with symptoms of nausea, shortness of breath, increase in blood pressure and pulse rate. It was reported that, doctor said that the increase in INR (international normalized ratio) was also from her immunization. The patient recovered from the events on an unspecified date. The reporter assessed the case as non-serious. Significant case correction received with IRD 06-Mar-2018: Reporter causality was changed from not reported to related. Company comment was changed from related to unassessable for the events INR increased, increased blood pressure and heart rate increased. Amended narrative accordingly.
Age: 71.0
Sex: F
Vaccine: FLUA3
Symptoms: Nausea
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 707300) concerns a 71-year-old female patient. The patient's historical condition included atrial fibrillation (A-fib as reported). The patient's historical drug included ELIQUIS. The patient's concomitant medications included Triamterene and hydrochlorothiazide, metformin, JANTOVEN, clonazepam, pantoprazole, promethazine. It was reported that, the patient underwent several heart related procedures. On 04-Aug-2017, the patient was administered with FLUAD (dose: 0.5ml (N/A as reported), route of administration: injection, anatomical location: left arm, batch number: 178301). On 05-Aug-2017, 1 day after vaccination, the patient felt sick with symptoms of nausea, shortness of breath, increase in blood pressure and pulse rate. It was reported that, doctor said that the increase in INR (international normalized ratio) was also from her immunization. The patient recovered from the events on an unspecified date. The reporter assessed the case as non-serious. Significant case correction received with IRD 06-Mar-2018: Reporter causality was changed from not reported to related. Company comment was changed from related to unassessable for the events INR increased, increased blood pressure and heart rate increased. Amended narrative accordingly.
Age: 31.0
Sex: M
Vaccine: FLUA3
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 707460), concerns a 31-year-old male patient. On 09-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right am, batch number: 178301). It was reported that, the patient was administered with vaccine at the age of 31 years and no symptoms were noted. The outcome of the event was not reported. The reporter assessed the case as non-serious.
Age: 84.0
Sex: M
Vaccine: FLUA3
Symptoms: Cough, Malaise, Throat irritation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 707608), concerning an 84-year-old elderly male patient. The patient had no known drug allergies. The patient's concomitant medications included RESTASIS, Quinapril, Atorvastatin, Escitalopram, Trazodone, HCTZ and Omeprazole. On 07-Aug-2017, the patient received FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178307 (as reported), expiry date: not reported). On the same day, after vaccination, the patient was not feeling well as he had cough in chest and itchy throat. The patient had not yet recovered from the events cough in chest, itchy throat and not feeling well. The reporter assessed this case as non-serious.
Age: 87.0
Sex: U
Vaccine: FLUA3, PPV
Symptoms: Dizziness
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 707759), concerning an 87-year-old, elderly patient of unspecified gender. The patient's medical history and concomitant medications were not reported. On 09-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: left arm, batch number: 178502, expiry date: not reported). On the same day, the patient was administered with PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: right arm, batch number: N003993, expiry date: not reported). On the same day after vaccination, the patient was dizzy at the counter and was about to fall. It was reported that, the patient made emergency room/physician office visit. At the time of this report, the outcome of the event was unknown. The reporter assessed the event as non-serious.
Age: 76.0
Sex: M
Vaccine: FLUA3
Symptoms: Computerised tomogram, Fatigue, Nausea, Restlessness, Vomiting
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708118), concerns a 76-year-old, elderly, male patient. The patient had no medical history and allergy. The patient did not receive any concomitant medication. On 09-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, batch number: 178303, anatomical location: left arm and expiry date: not reported). On the same day, after the vaccination, the patient had nausea and vomiting. The patient was also fatigue and restless. The patient called the 911 and went to the emergency room and physician office, where CT (computed tomography) scan was done for which results were not reported. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.
Age: 65.0
Sex: F
Vaccine: FLUA3
Symptoms: Asthenia, Chills, Dyskinesia, Headache, Pyrexia
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708257), concerns a 65-year-old elderly female patient. The patient was allergic to naproxen. On 11-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: injection, anatomical location: left arm, batch number and expiry date: not reported). On the same day, after the administration of vaccine, the patient experienced high fever, chills, headache, weakness and jerking motion. It was reported that, fever lasted for few hours and weakness for two and half day. The outcome of the events was recovered. The reporter assessed this case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The case comment was corrected.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Bone pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708301), concerns a 74-year-old, elderly female patient. The patient's current conditions included allergy to penicillin, sulfa drugs and LEVITRA. On 15-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml (reported as 1 dose), route of administration: intramuscular, anatomical location: right arm, batch number: 178301, expiry date: not reported). On the same day of vaccination, the patient experienced pain in the right collarbone. On an unspecified date, the pain had resolved and had no further complaints. The reporter assessed the case as non-serious.
Age: 66.0
Sex: M
Vaccine: FLUA3
Symptoms: Dyspnoea
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708346), concerns a 66-year-old, elderly, male patient. The patient's medical history, allergy and concomitant medications were not reported. On 14-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 178301 and expiry date: not reported). On 15-Aug-2018, after 1 day of vaccination, the patient had trouble in breathing. At the time of this report, the outcome of the event was not reported. The reporter assessed the event as non-serious.
Age: 59.0
Sex: F
Vaccine: FLUA3
Symptoms: Lethargy, Mass, Nausea, Pain, Palpitations
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708460), concerning a 59-year-old, adult female patient. The patient's historical condition included: depression. The patient was allergic to codeine. Concomitant medications included: EFFEXOR, lisinopril and KLONOPIN for an unknown indication. On 01-Oct-2016, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On 19-Oct-2016, after 18 days of vaccination, the patient felt feverish, nausea, racing heart, large swollen lump and very hot to the touch (approximately 2 inches x 1 inch). In addition, she had extreme lethargy. It was reported that, the condition lasted for over 48 hours. Ice was applied often to relieve pain and swelling. The patient had recovered from all the events. The reporter assessed this case as non-serious.
Age: 59.0
Sex: F
Vaccine: FLUA3
Symptoms: Pyrexia, Skin warm, Swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708460), concerning a 59-year-old, adult female patient. The patient's historical condition included: depression. The patient was allergic to codeine. Concomitant medications included: EFFEXOR, lisinopril and KLONOPIN for an unknown indication. On 01-Oct-2016, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). On 19-Oct-2016, after 18 days of vaccination, the patient felt feverish, nausea, racing heart, large swollen lump and very hot to the touch (approximately 2 inches x 1 inch). In addition, she had extreme lethargy. It was reported that, the condition lasted for over 48 hours. Ice was applied often to relieve pain and swelling. The patient had recovered from all the events. The reporter assessed this case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3, PNC13, TDAP, VARZOS
Symptoms: Myalgia, Pyrexia, Tinnitus
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708810), concerning a 65-year-old elderly male patient. The patient's medical and medication history were not reported. On 14-Aug-2017, the patient received FLUAD (dose: 0.5 ml (UNK as reported), route of administration: intramuscular, anatomical location: right arm, batch number: 178303 and expiry date: not reported), PREVNAR 13 (route of administration: intramuscular, anatomical location: right arm, dose, batch number: R70446 and expiry date: not reported) ADACEL (route of administration: intramuscular, anatomical location: left arm, dose, batch number 7Z9Z5 and expiry date: not reported) and ZOSTAVAX (route of administration: subcutaneous, anatomical location: right arm, dose, batch number: L025375 and expiry date: not reported). On 15-Aug-2017, the patient developed low grade fever, muscle soreness and tinnitus. The patient recovered from low grade fever and muscle soreness but not recovered from tinnitus. The reporter assessed the case as non-serious.
Age: 71.0
Sex: M
Vaccine: FLUA3, PPV
Symptoms: Fatigue, Headache, Injection site erythema, Pain
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708841), concerns a 71-year-old, elderly, male patient. The patient's historical condition, allergy and concomitant medications were not reported. The patient had no current conditions. On 14-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, batch number: 175503, anatomical location: right arm and expiry date: not reported) and non-company suspect product PNEUMOVAX (route of administration: intramuscular, anatomical location: right arm, batch number: M042599 and expiry date: not reported). On the same day, after the vaccination, the patient had injection site redness, headache, body aches (body pain) and he was very tired. At the time of this report, the outcome of the events was not reported. The reporter assessed the events as non-serious. Non-significant case correction received with IRD 06-Mar-218: Case comment was corrected.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Dizziness, Erythema, Facial pain, Fatigue, Headache
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708879), concerning a 67-year-old adult female patient. The patient was allergic to raw fish and concomitant medications included metoprolol succ ER, ADVAIR and Aspirin for an unknown indication. On 15-Aug-2017, the patient received FLUAD (TIV) (dose: 0.5 ml (reported as dose 1), anatomical location: right arm, batch number: 178502, route of administration and expiry date: not reported). On the same day, the patient received non-company suspect drug PNEUMOVAX (dose: 2 DF, anatomical location: left arm, batch number: N005076, route of administration and expiry date: not reported). On the same day, approximately 3-4 hours later, the patient had redness, soreness and swelling in the left arm. She also had jaw pain, cheek pain, dull headache and she felt fatigue and dizzy in the evening. She was advised to consult her provider and she was given cephalexin (dose: 500, thrice a day for 7 days), SMZ-TMP DS (dose: 800/60, twice a day for 7 days). The patient had recovered from the events (redness, soreness and swelling in the left arm, jaw pain, cheek pain, dull headache, fatigue and dizzy). The reporter assessed this case as non-serious.
Age: 67.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Pain in extremity, Pain in jaw, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708879), concerning a 67-year-old adult female patient. The patient was allergic to raw fish and concomitant medications included metoprolol succ ER, ADVAIR and Aspirin for an unknown indication. On 15-Aug-2017, the patient received FLUAD (TIV) (dose: 0.5 ml (reported as dose 1), anatomical location: right arm, batch number: 178502, route of administration and expiry date: not reported). On the same day, the patient received non-company suspect drug PNEUMOVAX (dose: 2 DF, anatomical location: left arm, batch number: N005076, route of administration and expiry date: not reported). On the same day, approximately 3-4 hours later, the patient had redness, soreness and swelling in the left arm. She also had jaw pain, cheek pain, dull headache and she felt fatigue and dizzy in the evening. She was advised to consult her provider and she was given cephalexin (dose: 500, thrice a day for 7 days), SMZ-TMP DS (dose: 800/60, twice a day for 7 days). The patient had recovered from the events (redness, soreness and swelling in the left arm, jaw pain, cheek pain, dull headache, fatigue and dizzy). The reporter assessed this case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Asthenia, Back pain, Blood glucose increased, Blood test, Chest X-ray normal
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708930), concerns a 66-year-old, elderly, female patient. The patient's historical conditions included back pain from fractures, degenerative disc, stenosis. The patient underwent total knee replacement on unspecified date. The patient's current conditions included pre-diabetes, dry eyes, allergic to yeast, gluten, mold, some shellfish, and sulphite (since an unspecified dates). The patient's concomitant medications included SYNTHROID, LIPITOR, hydrochlorothiazide, lisinopril, gabapentin, FELDENE, Multiple vitamins, Probiotic, SAME, potassium, Flax Seed Oil and Aspirin for an unknown indication. On 15-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On 16-Aug-2017, after 1 day of vaccination, the patient had high temperature, pain in groin, upper thigh and lower back. The patient had loss of appetite, increased glucose levels, blurred vision and extremely low energy level. It was reported that the patient was unable to walk. The patient's arm was sore, swollen and red. On an unspecified date, the patient made physician office visit. On an unspecified date, chest X-ray was performed, the result was negative for illness, blood tests were done, white blood cells (WBC) found to be elevated and urine analysis was performed, the result was negative for infection. It was reported that, the patient was high tolerance for pain. At the time of this report, the outcome of all the events had not recovered. The reporter considered the case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Decreased appetite, Gait inability, Groin pain, Pain in extremity, Peripheral swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708930), concerns a 66-year-old, elderly, female patient. The patient's historical conditions included back pain from fractures, degenerative disc, stenosis. The patient underwent total knee replacement on unspecified date. The patient's current conditions included pre-diabetes, dry eyes, allergic to yeast, gluten, mold, some shellfish, and sulphite (since an unspecified dates). The patient's concomitant medications included SYNTHROID, LIPITOR, hydrochlorothiazide, lisinopril, gabapentin, FELDENE, Multiple vitamins, Probiotic, SAME, potassium, Flax Seed Oil and Aspirin for an unknown indication. On 15-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On 16-Aug-2017, after 1 day of vaccination, the patient had high temperature, pain in groin, upper thigh and lower back. The patient had loss of appetite, increased glucose levels, blurred vision and extremely low energy level. It was reported that the patient was unable to walk. The patient's arm was sore, swollen and red. On an unspecified date, the patient made physician office visit. On an unspecified date, chest X-ray was performed, the result was negative for illness, blood tests were done, white blood cells (WBC) found to be elevated and urine analysis was performed, the result was negative for infection. It was reported that, the patient was high tolerance for pain. At the time of this report, the outcome of all the events had not recovered. The reporter considered the case as non-serious.
Age: 66.0
Sex: F
Vaccine: FLUA3
Symptoms: Pyrexia, Skin reaction, Urine analysis normal, Vision blurred, White blood cell count increased
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 708930), concerns a 66-year-old, elderly, female patient. The patient's historical conditions included back pain from fractures, degenerative disc, stenosis. The patient underwent total knee replacement on unspecified date. The patient's current conditions included pre-diabetes, dry eyes, allergic to yeast, gluten, mold, some shellfish, and sulphite (since an unspecified dates). The patient's concomitant medications included SYNTHROID, LIPITOR, hydrochlorothiazide, lisinopril, gabapentin, FELDENE, Multiple vitamins, Probiotic, SAME, potassium, Flax Seed Oil and Aspirin for an unknown indication. On 15-Aug-2017, the patient was administered with FLUAD (TIV) (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number and expiry date: not reported). On 16-Aug-2017, after 1 day of vaccination, the patient had high temperature, pain in groin, upper thigh and lower back. The patient had loss of appetite, increased glucose levels, blurred vision and extremely low energy level. It was reported that the patient was unable to walk. The patient's arm was sore, swollen and red. On an unspecified date, the patient made physician office visit. On an unspecified date, chest X-ray was performed, the result was negative for illness, blood tests were done, white blood cells (WBC) found to be elevated and urine analysis was performed, the result was negative for infection. It was reported that, the patient was high tolerance for pain. At the time of this report, the outcome of all the events had not recovered. The reporter considered the case as non-serious.
Age: 65.0
Sex: M
Vaccine: FLUA3, VARZOS
Symptoms: Erythema, Joint swelling, Peripheral swelling
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709079), concerns a 65-year-old elderly male patient. On 11-Aug-2017, the patient was administered with FLUAD (dose: 0.5ml (2 as reported), route of administration: unknown, anatomical location: right arm, batch number: 178503 and expiry date: not reported) and ZOSTAVAX (dose: 1 DF, route of administration: unknown, anatomical location: left arm, batch number: M041087 and expiry date: not reported). On 13-Aug-2017, 2 days after vaccination, the patient's arm, elbow, forearm, wrist became red and swollen. The patient went for urgent care, prescribed with cephalexin for 10 days. The outcome of the events was recovered. The reporter assessed the case as non-serious. Non-significant case correction received with IRD 06-Mar-2018: The co-suspect vaccine (ZOSTAVAX) was captured in case comment.
Age: 74.0
Sex: F
Vaccine: FLUA3
Symptoms: Dyspnoea, Feeling abnormal, Hypertension, Thirst
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709089), concerning a 74-year-old, elderly female patient. The patient's medical history and concomitant medication was not reported. On 18-Aug-2017, the patient received FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location, right arm, batch number: 178323, expiry date: not reported). On the same day, after administration of vaccine, the patient did not feel right, blood pressure was high, had extreme thirst and shortness of breath. After 5 minutes, breathing was further laboured. Emergency medical services were sought and the patient was administered with EPIPEN. The outcome of the events was unknown. The reporter assessed this case as non-serious.
Age: 67.0
Sex: M
Vaccine: FLUA3, PNC13
Symptoms: Abnormal dreams, Feeding disorder, Influenza like illness, Insomnia, Loss of personal independence in daily activities
Clinical narrative: This spontaneous case, reported by Non-health care professional (other) to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709101), concerns a 67-year-old, elderly, male patient. The patient had no current condition. On 07-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178502 and expiry date: not reported) and PREVNAR 13 (dose: unknown, route of administration: intramuscular, anatomical location: left arm, manufacturer, trade, batch number and expiry date: not reported). On the same day after vaccination, the patient developed flu like symptoms and at night he had vivid dreams (felt like talking himself, like out of body conversations), it was lasted for three nights. The patient could not sleep, eat, or not able to do anything except lay on bed. At the end of this report, the outcome of the events was recovered. The reporter considered the case as non-serious.
Age: 68.0
Sex: F
Vaccine: FLUA3, PPV
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site swelling, Oedema peripheral
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 06-Mar-2018 by Seqirus from VAERS (VAERS ID: 709170), concerning a 68-year-old, elderly female patient. The patient's historical condition included: irritable bowel disease, acid reflux, depression, hot flashes. The patient was allergic to doxycycline, Sulfacetamide, sulfa antibiotics, TUSSIONEX and Morphine. On 07-Aug-2017, the patient was administered with FLUAD (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: 178502, expiry date: not reported. On the same day, the patient was administered with non-company suspect PNEUMOVAX (dose: 1 DF, route of administration: intramuscular, anatomical location: left arm, batch number: N010105, expiry date: not reported). About 1 and 1/2 hours after receiving PNEUMOVAX 23, the patient's entire left arm became red, swollen and very sore. The next day, she examined her arm and could find no evidence of redness. Both arms appeared somewhat "puffy" and fingers edematous. It was reported that, the patient's fingers on the left hand appeared slightly more swollen than on right hand. She took TYLENOL and MOTRIN for the pain. Subsequently, the pain was lessened but arm was still somewhat sore. The patient had not yet recovered from all the events (redness, swelling arm, pain in arm, edema fingers, injection site redness, injection site swelling and injection site pain). The reporter assessed the events as non-serious. Non-significant case correction received 06-Mar-2018: Case comment was corrected.